Quick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC148490/Quick-Listen-Scrips-Five-MustKnow-Things ..read more

Pink Sheet reporters and editors discuss CMS’s latest coverage announcement for Alzheimer’s drugs and the VA’s approach to the issue (0:29), the FDA’s new one-page patient medication information document (15:55), international convergence on COVID-19 vaccine strain selection (24:48), and Novavax’s place in the vaccine toolbox going forward (28:21). Read More In The Pink Sheet Medicare Registry Plan For Alzheimer’s Drugs Pairs CMS Web Portal With Health System Efforts https://pink.pharmaintelligence.informa.com/PS148313/Medicare-Registry-Plan-For-Alzheimers-Drugs-Pairs-CMS-Web-Portal-With-Healt ..read more

NSCLC Disease Analysis Report https://service.datamonitorhealthcare.com/hkc/disease/oncology/lung-cancer/non-small-cell-lung-cancer/disease-analysis/article218222.ece NSCLC Forecast https://service.datamonitorhealthcare.com/hkc/disease/oncology/lung-cancer/non-small-cell-lung-cancer/forecast/article141043.ece HER2+ Breast Cancer Disease Analysis Report https://service.datamonitorhealthcare.com/hkc/disease/oncology/gynecological-cancer/breast-cancer-her2-positive/disease-analysis/article213383.ece HER2+ Breast Cancer Forecast https://service.datamonitorhealthcare.com/hkc/disease/oncology/gyneco ..read more

Regulatory strategists present key publishing strategies to consider when planning your marketing application for successful regulatory outcomes. Don’t miss insights into creating your strongest marketing application strategy, with guidelines from experts at Veristat. You’ll learn more about the important steps to follow for: • Building a publishing-specific team and educating stakeholders about the document submission process • Creating an effective communication strategy • Mitigating delays • Understanding timelines • And much more ..read more

Successfully navigate the complexities of the Chemical, Manufacturing, and Controls (CMC) portions of Investigational New Drug (IND) applications. Listen in as experts provide their insider perspectives on common CMC- and IND- related questions ..read more

Listen to expert perspectives on the recent history of DEI in clinical trials and the barriers to patient participation. Listen now to a lively and informative discussion that addresses the questions: • What has changed in patient recruitment strategies from pre- to post-COVID and why? • What factors influenced a new focus on DEI during the time of COVID? • What are the barriers to DEI for patient recruitment in Phase I and Phase II studies? • And more ..read more

Quick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC148456/Quick-Listen-Scrips-Five-MustKnow-Things ..read more

HBW Insight catches up with our own US Executive Editor, Malcolm Spicer, to find out all about Perrigo subsidiary HRA Pharma’s Rx-to-OTC switch of its daily contraceptive, Opill. Currently under consideration by the US Food and Drug Administration after a positive recommendation from its advisory committees, Spicer draws on 30+ years of writing about the US consumer healthcare market, as well as his extensive coverage of the subject, to tell us all we need to know about this historic switch ..read more

Quick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC148417/Quick-Listen-Scrips-Five-MustKnow-Things ..read more

Brian Yang and Dexter Yan discuss the latest China biotech trends and topics including recent mega-million deals between domestic biotechs and MNCs, the inaugural Asia Bio Partnering Forum and drug makers’ creative ways to financing amid lingering “capital winter”, and GLP-1 receptor agonists stepping into the spotlight and its potential to become the next hot pursuit after PD-1 in China ..read more